AP NEWS

Bristol-Myers Squibb to Take Part in Citi 2018 Global Healthcare Conference

November 29, 2018

NEW YORK--(BUSINESS WIRE)--Nov 29, 2018--Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Citi 2018 Global Healthcare Conference on Thursday, December 6, 2018 in New York. Tom Lynch, chief scientific officer, will answer questions about the company at 2:10 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181129005019/en/

CONTACT: Media:Carrie Fernandez, 609-252-5222,carrie.fernandez@bms.com

Investors: Tim Power, 609-252-7509,timothy.power@bms.comor Bill Szablewski,

609-252-5894,william.szablewski@bms.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL

SOURCE: Bristol-Myers Squibb Company

Copyright Business Wire 2018.

PUB: 11/29/2018 06:59 AM/DISC: 11/29/2018 06:59 AM

http://www.businesswire.com/news/home/20181129005019/en

AP RADIO
Update hourly